Androgenetic alopecia. New approved and unapproved treatments (Q33811504)

29 July 2017

1 reference

title

Androgenetic alopecia. New approved and unapproved treatments (English)

1 reference

29 July 2017

1 reference

Sawaya ME

1

1 reference

29 July 2017

Shapiro J

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

47-61, viii

1 reference

Clinical pharmacokinetics of diuretics

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

The psychological effects of androgenetic alopecia in men

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial**Supported in part by Schering-Plough, Pointe-Claire, Québec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

The effect of spironolactone on hirsutism and female androgen metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Activation, transformation, and subunit structure of steroid hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Side-effects of spironolactone therapy in the hirsute woman

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Characterization of 5 alpha-reductase in cultured human dermal papilla cells from beard and occipital scalp hair

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Hair loss with minoxidil withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

The inheritance of common baldness: two B or not two B?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

A Comparative Study of a New Food Supplement, ViviScal®, with Fish Extract for the Treatment of Hereditary Androgenic Alopecia in Young Males

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

The biological effects of a pulsed electrostatic field with specific reference to hair. Electrotrichogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Electrotrichogenesis: further evidence of efficacy and safety on extended use.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Pharmacology of antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Sulfhydryl group content of chicken progesterone receptor: effect of oxidation on DNA binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Clinical updates in hair

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Purification of androgen receptors in human sebocytes and hair

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

delta 5-3 beta-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Immunohistochemical distribution of aromatase and 3B-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Regulation of human hair growth by steroid hormones. II. Androstenedione metabolism in isolated hairs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Hair regrowth. Therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

Fatal and Nonfatal Hepatotoxicity Associated with Flutamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

The endocrine effects of spironolactone used as an antiandrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970146-7

7 January 2021

10.1016/S0733-8635(05)70146-7

Identifiers

DOI

1 reference

29 July 2017

1 reference